GAO Finds Significant Fraud Risks in ACA Subsidy Programs
A GAO report reveals extensive fraud risks in ACA marketplace subsidy programs, prompting calls for regulatory reforms to protect taxpayers and improve healthcare affordability.
Key Swing District Republicans Push to Extend ACA Premium Tax Credits Amid Rising Costs
Republicans in competitive House districts seek extension of ACA premium tax credits to mitigate 2026 health insurance premium increases and address voter affordability concerns.
ACA Premium Tax Credit Expiration Raises Insurance Costs and Political Stakes in 2026
As enhanced ACA premium tax credits expire, insured Americans face soaring premiums, prompting bipartisan legislative efforts and political debates ahead of the 2026 midterms.
ACA Subsidy Expiration Threatens 26% Premium Increase for Enrollees
Expiration of ACA healthcare subsidies in 2026 could trigger a 26% average premium increase, impacting millions of enrollees. Strategies for managing rising costs include budgeting and debt counseling.
Congress Faces Health Care Policy Crossroads Over ACA Subsidies and Costs
Congress is at a critical juncture on health care policy with votes on ACA subsidies extension, rising prescription drug costs, and state-led premium support amid federal debates.
GOP Proposal to Redirect Obamacare Subsidies to Health Savings Accounts
Summary of GOP-backed plan to shift Obamacare subsidies directly to patients via health savings accounts, highlighting implications for health insurance policy and consumer-directed spending.
Senate ACA Subsidy Vote, FTC Case, Federal Education Staffing, Corpus Christi Water Projects
Key updates on the Senate vote to extend ACA subsidies, Supreme Court FTC case, federal Education Department staffing, and Corpus Christi water project developments.
Health Insurance Affordability: Policy Challenges and Market Implications
Explore how affordability challenges in health insurance impact regulatory policy and market dynamics. Insights on maintaining balance in health insurance costs and coverage.
CARsgen's CAR-T Therapy Zevor-cel Added to China's Insurance Innovative Drug Catalogue
CARsgen Therapeutics' CAR-T therapy zevor-cel gains inclusion in China's 2025 Innovative Drug Catalogue, highlighting regulatory support and improved patient access for relapsed/refractory multiple myeloma treatment.
ACA Approval Hits Record High Driven by Independent Voter Support
Public approval of the Affordable Care Act reaches a new high amid debate over upcoming expiration of enhanced healthcare subsidies, driven by rising support among independents.